Social Media Influencers Driving Unofficial Market for Unlicensed Weight-Loss Drug
A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Investigational Treatment Acquiring Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these profiles directly for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a robust trade exists on messaging services, where communities with numerous of members share “before and after” images, injection guides and assertions of next-day British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Professionals Express Worries
However, physicians and chemists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.
Several experts stated the popularity for the experimental drug could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.
Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, advertising, and consumer laws, risking fines, prosecution or prison.
Service Reaction and Material Elimination
Based on the social media company, the platform has taken down violative content and prohibited related keywords and search suggestions. The organization stated it was committed to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Research also found communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, filled with images of slimming results, glowing testimonials and step-by-step guides for mixing or administering at residence.
After moments of entering one group, a vendor posted WhatsApp details, where most transactions occur. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or past usage.
Item Details and Costs
Inside these groups, messages display dark colored packages with postal service labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A representative for Telegram stated it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they can’t verify. Although the science behind retatrutide is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.
Her team has already encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject users to possibly significant medical dangers”.